Evidence map›Paper›PMID 28935654›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Opioid Prescription, Morbidity, and Mortality in United States Dialysis Patients.

Paul L Kimmel, Chyng-Wen Fwu, Kevin C Abbott, Anne W Eggers, Prudence P Kline, Paul W Eggers

Registry-linked trialAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07421674 (Application Research of Hydromorphinone Sustained-release Tablets in the Treatment of Elderly Patients With Cancer Pain Accompanied by Renal Insufficiency), which is not on this map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07421674 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Application Research of Hydromorphinone Sustained-release Tablets in the Treatment of Elderly Patients With Cancer Pain Accompanied by Renal Insufficiency

Typeobservational_patient_registrySponsorTaian Cancer HospitalRan2026 to 2028Enrolled62ConditionsCancer Pain, Renal Insufficiency Chronic, Hydromorphone Use
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 120 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Association of Coprescribing of Gabapentinoid and Other Psychoactive Medications With Altered Mental Status and Falls in Adults Receiving Dialysis.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Observational
  11. Article
  12. Need to Advance Pain Management in Kidney Failure beyond Opioid Medications.Journal of the American Society of Nephrology : JASN · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Opioid prescription and diabetes among Medicare beneficiaries.Diabetes research and clinical practice · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Paul L KimmelDivision of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; kimmelp@extra.niddk.nih.gov.
Chyng-Wen FwuSocial and Scientific Systems, Inc., Silver Spring, Maryland.
Kevin C AbbottDivision of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Anne W EggersConsultant Pharmacist, Olney, Maryland; and.
Prudence P KlineDepartment of Medicine, George Washington University, Washington, DC.
Paul W EggersDivision of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
National Institutes of Health · USAmerican Pharmacists Association · USGeorge Washington University · USSocial and Scientific Systems (United States) · US

Funding

NIDDK NIH HHS HHSN276201200161U
6 · The paper itself

Abstract

Aggressive pain treatment was advocated for ESRD patients, but new Centers for Disease Control and Prevention guidelines recommend cautious opioid prescription. Little is known regarding outcomes associated with ESRD opioid prescription. We assessed opioid prescriptions and associations between opioid prescription and dose and patient outcomes using 2006-2010 US Renal Data System information in patients on maintenance dialysis with Medicare Part A, B, and D coverage in each study year (

Indexed as

Pain ManagementPractice Patterns, Physicians'Renal DialysisAdultAgedAnalgesics, OpioidCenters for Disease Control and Prevention, U.S.Cohort StudiesData CollectionDrug PrescriptionsFemaleFluid TherapyHumansKidney Failure, ChronicMaleMedicareAnalgesics, Opioiddialysisend stage kidney diseaseEpidemiology and outcomesmortalityUnited States Renal Data System

Identifiers

PMID28935654
PMCPMC5698071
OpenAlexW2758032729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.